黑料网

ISSN: 2165-7386

Journal of Palliative Care & Medicine
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • J Palliat Care Med 366,
  • DOI: 10.4172/2165-7386.1000366

Exacerbation of Extrapyramidal Symptoms Associated with Drug-induced Akathisia after Intramuscular Administration of Biperiden in a Patient with End-stage Gastric Cancer A Case Report

Ryo Sakamoto1,2*, Hiromichi Matsuoka1,2, Emi Gomi2, Akinori Kawaguchi3, Shiho Takehisa2 and Atsuko Koyama1,2
1Department of Psychosomatic Medicine, Kindai University, Japan
2Centre for Palliative Care, Kindai University Hospital, Japan
3Department of Pharmacy, Kindai University Hospital, Japan
*Corresponding Author : Ryo Sakamoto, Department of Psychosomatic Medicine, Kindai University, Ohno-higashi, Osakasayama City, Osaka, Japan, Tel: +96-32232944, Email: ryo-sakamoto@med.kindai.ac.jp

Received Date: Nov 22, 2019 / Accepted Date: Nov 30, 2019 / Published Date: Dec 06, 2019

Abstract

Background: The Anti-cholinergic drug Biperiden is used to treat Parkinsonism, Parkinsonism as an adverse effect of Psychotropic drugs, Dyskinesia, and Akathisia. In the palliative care field, Biperiden is used to treat Akathisia that has developed as an adverse effect of antipsychotics for managing delirium. There are tablets, granules, and injectable preparations of this drug; thus, it can be used for patients with various conditions.

Discussion: In addition to changing and withdrawing the causative drug, Propranolol, Mirtazapine, and Biperiden, an anticholinergic drug, may be administered to manage drug-induced Akathisia. However, Biperiden used to treat drug-induced Akathisia may exacerbate the Akathisia.

Conclusion: Here, we describe administering intramuscular Biperiden to a patient with gastric cancer at the end of life. When Biperiden is administered to treat drug-induced Akathisia and exacerbation of the Akathisia occurs, it is important to consider whether the deterioration in Akathisia is caused by the Biperiden, rather than simply continuing to administer it.

Keywords: Exacerbation of Extrapyramidal Symptoms; Drug-induced Akathisia; Biperiden; Cancer

Citation: Sakamoto R, Matsuoka H, Gomi E, Kawaguchi A, Takehisa S, et al. (2019) Exacerbation of Extrapyramidal Symptoms Associated with Drug-induced Akathisia after Intramuscular Administration of Biperiden in a Patient with Endstage Gastric Cancer: A Case Report. J Palliat Care Med 9:366 Doi: 10.4172/2165-7386.1000366

Copyright: © 2019 Sakamoto R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Post Your Comment Citation
Share This Article
Recommended Conferences

Toronto, Canada

Toronto, Canada
Article Tools
Article Usage
  • Total views: 2229
  • [From(publication date): 0-2020 - Nov 25, 2024]
  • Breakdown by view type
  • HTML page views: 1635
  • PDF downloads: 594
International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top